» Articles » PMID: 23671329

Suppression of Ser/Thr Phosphatase 4 (PP4C/PPP4C) Mimics a Novel Post-mitotic Action of Fostriecin, Producing Mitotic Slippage Followed by Tetraploid Cell Death

Overview
Journal Mol Cancer Res
Specialty Cell Biology
Date 2013 May 15
PMID 23671329
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Fostriecin is a natural product purified from Sterptomyces extracts with antitumor activity sufficient to warrant human clinical trials. Unfortunately, difficulties associated with supply and stable drug formulation stalled further development. At a molecular level, fostriecin is known to act as a catalytic inhibitor of four PPP-family phosphatases, and reports describing the design of molecules in this class suggest derivatives targeting enzymes within the fostriecin-sensitive subfamily can be successful. However, it is not clear if the tumor-selective cytotoxicity of fostriecin results from the inhibition of a specific phosphatase, multiple phosphatases, or a limited subset of fostriecin sensitive phosphatases. How the inhibition of sensitive phosphatases contributes to tumor-selective cytotoxicity is also not clear. Here, high-content time-lapse imaging of live cells revealed novel insight into the cellular actions of fostriecin, showing that fostriecin-induced apoptosis is not simply induced following a sustained mitotic arrest. Rather, apoptosis occurred in an apparent second interphase produced when tetraploid cells undergo mitotic slippage. Comparison of the actions of fostriecin and antisense-oligonucleotides specifically targeting human fostriecin-sensitive phosphatases revealed that the suppression PP4C alone is sufficient to mimic many actions of fostriecin. Importantly, targeted suppression of PP4C induced apoptosis, with death occurring in tetraploid cells following mitotic slippage. This effect was not observed following the suppression of PP1C, PP2AC, or PP5C. These data clarify PP4C as a fostriecin-sensitive phosphatase and demonstrate that the suppression of PP4C triggers mitotic slippage/apoptosis.

Implications: Future development of fostriecin class inhibitors should consider PP4C as a potentially important target. Mol Cancer Res; 11(8); 845-55. ©2013 AACR.

Citing Articles

PP4 inhibition sensitizes ovarian cancer to NK cell-mediated cytotoxicity via STAT1 activation and inflammatory signaling.

Raja R, Wu C, Bassoy E, Rubino Jr T, Utagawa E, Magtibay P J Immunother Cancer. 2022; 10(12).

PMID: 36564125 PMC: 9791393. DOI: 10.1136/jitc-2022-005026.


Coordination of Protein Kinase and Phosphoprotein Phosphatase Activities in Mitosis.

Nasa I, Kettenbach A Front Cell Dev Biol. 2018; 6:30.

PMID: 29623276 PMC: 5874294. DOI: 10.3389/fcell.2018.00030.


Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.

Li M, Li X, Xu S, Xue P, Li Q, Lu Q Tumour Biol. 2016; 37(9):11893-11901.

PMID: 27059736 DOI: 10.1007/s13277-016-5054-6.


High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.

Li X, Liang L, Huang L, Ma X, Li D, Cai S Mol Cancer. 2015; 14:95.

PMID: 25927939 PMC: 4416320. DOI: 10.1186/s12943-015-0356-7.

References
1.
Huang X, Cheng A, Honkanen R . Genomic organization of the human PP4 gene encoding a serine/threonine protein phosphatase (PP4) suggests a common ancestry with PP2A. Genomics. 1997; 44(3):336-43. DOI: 10.1006/geno.1997.4891. View

2.
Lewy D, Gauss C, Soenen D, Boger D . Fostriecin: chemistry and biology. Curr Med Chem. 2002; 9(22):2005-32. DOI: 10.2174/0929867023368809. View

3.
Hotz M, Traganos F, Darzynkiewicz Z . Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Exp Cell Res. 1992; 201(1):184-91. DOI: 10.1016/0014-4827(92)90362-c. View

4.
Le L, Erlichman C, Pillon L, Thiessen J, Day A, Wainman N . Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days. Invest New Drugs. 2004; 22(2):159-67. DOI: 10.1023/B:DRUG.0000011792.13160.b0. View

5.
Lera R, Burkard M . High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells. J Biol Chem. 2012; 287(51):42812-25. PMC: 3525009. DOI: 10.1074/jbc.M112.412544. View